“
“Ecologists and conservation biologists need to identify the relative importance of species to make sound management decisions and effectively

allocate scarce resources. https://www.selleckchem.com/products/sis3.html We introduce a new method, termed environ centrality, to determine the relative importance of a species in an ecosystem network with respect to ecosystem energy-matter exchange. We demonstrate the uniqueness of environ centrality by comparing it to other common centrality metrics and then show its ecological significance. Specifically, we tested two hypotheses on a set of 50 empirically based ecosystem network models. The first concerned the distribution of centrality in the community. We hypothesized that the functional importance of species would tend to be concentrated into a few dominant species followed by a group of species with lower, more even importance as is often seen in dominance-diversity curves. Second, we tested the systems ecology hypothesis that indirect relationships homogenize the functional importance of species in ecosystems. Our results support both hypotheses and highlight the importance of detritus and nutrient recyclers such as fungi and bacteria in generating the energy-matter flow in ecosystems. Our homogenization results suggest that indirect effects are important in

part because they tend to even the importance of species in ecosystems. A core contribution of this work is that it creates a formal, mathematical method to quantify the importance

species play in generating ecosystem activity click here by integrating direct, indirect, and boundary effects in ecological systems. (C) 2011 Elsevier Ltd. All rights reserved.”
“Emotional processing measures are sensitive to acute administration of clinically useful antidepressant drugs. We wished to test Glutamate dehydrogenase the hypothesis that these models would also be able to detect agents likely to cause depression as an adverse effect. The anti-obesity drug and cannabinoid type 1 receptor antagonist, rimonabant, is associated with significant rates of depression and anxiety in clinical use.

Thirty healthy adult volunteers were randomly assigned to receive a single dose of rimonabant (20 mg) or lactose placebo in a double-blind, between-groups design. Three hours after medication administration, subjects undertook an emotional processing test battery including facial emotion recognition, emotional word attentional dot probe, self-relevant word classification, emotional and declarative memory and the emotion-potentiated acoustic startle response. Subjective state was assessed via self-report measures.

A single dose of rimonabant did not alter subjective mood. However, rimonabant selectively reduced incidental recall of positive self-relevant adjectives, an effect contrary to that seen following the administration of antidepressants.